SCROLL NEWS / DISCOVERY

Search headlines

Find the stories shaping the conversation.

Search mode
Refine results
Active filters Keyword All time

Results for " 135 million " 17 found 🔀 AI-powered Shuffle

Sign in to save shuffle history.

Phillies sign pitcher Jesus Luzardo to five-year contract extension

The Phillies have signed Jesus Luzardo to a five-year, $135 million extension, keeping the left-hander in Philadelphia through the 2031 season.

nbcsportsphiladelphia.com logo
Mar 9 • 6:23 PM EDT • Sports • nbcsportsphiladelphia.com
Jeld-Wen secures $135 million in capital, extends debt maturities

Jeld-Wen Holdings has negotiated with creditors a $135 million capital infusion and an extension of 2027 and 2028 debt maturities, giving the Charlotte-based window and door maker a liquidity cushion to sharpen operations in the persistent housing slump. Jeld-Wen said earlier today it expects to extend the maturity of 2027 senior notes and 2028 term […]

businessnc.com logo
Sep 29 • 2:03 PM EDT • Business • businessnc.com
Kroenke Sports and Entertainment announces Ball Arena renovations

Kroenke Sports and Entertainment announced a $135 million renovation of Ball Arena.

gazette.com logo
Sep 18 • 2:05 PM EDT • Entertainment • gazette.com
‘Massive’ renovations coming to Ball Arena

Kroenke Sports & Entertainment announced a $135 million renovation set to be complete in three years.

kdvr.com logo
Sep 18 • 2:01 PM EDT • Entertainment • kdvr.com
NC’s State Health Plan sues Atrium, saying it can’t set plan members’ copays

The plan says it may not be able to pay its bills by January and is counting on its new tiered network to save $135 million.

newsobserver.com logo
Oct 9 • 1:20 PM EDT • Health • newsobserver.com
Jordan Love, Packers offense give Patriots' $135 million cornerback nightmares
sports.yahoo.com logo
Nov 8 • 9:06 PM EST • Sports • sports.yahoo.com
🙂 Positive (50%)
Rochester to receive $20M in aid as part of state budget

It's part of a $135 million package of additional funding, on top of Gov. Kathy Hochul's original budget proposal, to help distressed cities across the state.

spectrumlocalnews.com logo
May 28 • 11:04 AM EDT • Politics • spectrumlocalnews.com
Christian Gonzalez signs historic new deal with Patriots

Christian Gonzalez has signed a four-year, $135 million contract extension with the New England Patriots, making him the highest-paid cornerback in NFL history.

sports.yahoo.com logo
Sep 8 • 6:00 AM EDT • Sports • sports.yahoo.com
Kroenke Sports and Entertainment announces Ball Arena renovations

Kroenke Sports and Entertainment announced a $135 million renovation of Ball Arena.

denvergazette.com logo
Sep 18 • 2:05 PM EDT • Entertainment • denvergazette.com
Patriots make Christian Gonzalez the NFL's highest-paid cornerback, AP sources say

Christian Gonzalez has agreed to a four-year, $135 million contract with the New England Patriots that makes him the highest-paid cornerback in NFL history, two people with knowledge of the deal told The Associated Press on Tuesday. One of the people said Gonzalez is getting $102 million guaranteed. Gonzalez surpassed Devon Witherspoon's new contract from the Seattle Seahawks.

sports.yahoo.com logo
Sep 8 • 9:54 AM EDT • Sports • sports.yahoo.com
Medicus Pharma proposes $135M SkinJect spinout through SPAC business combination

Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to discuss a proposed transaction involving the company's wholly owned subsidiary, SkinJect, which has entered into a non-binding letter of intent with an undisclosed special purpose acquisition company (SPAC) for a potential business combination. The proposed transaction contemplates a US$135 million pre-money enterprise valuation for SkinJect, alongside a concurrent equity financing intended to support the company's SKNJCT-005 clinical study in patients with Gorlin syndrome and preparations for a potential New Drug Application (NDA). Bokhari told Proactive that the proposed deal is designed to establish SkinJect as a separately listed company focused on advancing its dermatology and rare-disease development program. Under the proposed structure, the SPAC would acquire 100% of SkinJect in exchange for newly issued common shares in the combined company. Medicus Pharma intends to retain majority economic and voting ownership, allowing existing Medicus shareholders to maintain significant participation in SkinJect's potential future value. The separation would also provide SkinJect with a dedicated financing platform to fund its clinical development activities, particularly the SKNJCT-005 study targeting Gorlin syndrome, a rare genetic condition associated with the development of multiple basal cell carcinomas. The concurrent financing is expected to support the clinical program and the work required to prepare and potentially submit a New Drug Application, subject to successful development and regulatory progress. Final ownership percentages have not yet been determined. These will depend on negotiations surrounding the definitive transaction agreement and the combined company's capitalization, including retained SPAC cash, public and sponsor shares, warrants and other potentially dilutive securities. Medicus said the proposed transaction remains subject to the completion of definitive documentation and other customary conditions. The planned spinout represents a strategic step in Medicus Pharma's efforts to give SkinJect a dedicated corporate and financial structure, while allowing the parent company to retain majority participation as the dermatology program advances towards its next clinical and regulatory milestones. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #SkinJect #Biotechnology #Healthcare #RareDisease #GorlinSyndrome #Dermatology #SPAC #ClinicalTrials #DrugDevelopment #NDA #Biopharmaceuticals

finance.yahoo.com logo
Nov 5 • 11:27 AM EST • Business • finance.yahoo.com
HRSA Announces More Than $135 Million to Expand Nutrition Services and Strengthen Rural Health Workforce

HHS announced an important investment during a Preventative Care Roundtable with key stakeholders.

hhs.gov logo
Apr 7 • 5:00 PM EDT • Health • hhs.gov
Contract grade for Christian Gonzalez's $135 million extension with Patriots

It’s about time . One of the many stories around the New England Patriots this offseason was their contract negotiations with star cornerback Christian Gonzalez. Gonzalez firmly entrenched himself as one of the best cornerbacks in the league last season. With the 2026 season being his fourth season in the league, Gonzalez was due for a contract […] The post Contract grade for Christian Gonzalez's $135 million extension with Patriots appeared first on ClutchPoints.

sports.yahoo.com logo
Sep 8 • 2:19 AM EDT • Sports • sports.yahoo.com
Patriots' Christian Gonzalez sends immediate reaction to massive contract extension

It is finally over. The New England Patriots and Christian Gonzalez waited until less than two days before opening kickoff to get a deal done, but they have agreed to a record-breaking, four-year, $135 million contract extension. Fans can take a deep breath , and so can the highest-paid cornerback in NFL history. “Thank you Lord!” he posted on […] The post Patriots' Christian Gonzalez sends immediate reaction to massive contract extension appeared first on ClutchPoints.

sports.yahoo.com logo
Sep 8 • 3:16 AM EDT • Sports • sports.yahoo.com
Avalon’s New Challenges, Opportunities in Life Science Investing

LA JOLLA – As Avalon BioVentures wraps up deploying its very first fund, the $135 million ABV1, the early stage focused venture capital firm is already lookin

sdbj.com logo
Mar 24 • 8:00 AM EDT • Science • sdbj.com
I swore an oath to the Constitution, not a political party

This solution in search of a problem will come at great cost; closed primaries will cost the state more than $135 million over 10 years, according to the Secretary of State’s estimate.

lailluminator.com logo
Apr 9 • 9:44 AM EDT • Politics • lailluminator.com
Century Therapeutics Reports Full Year 2025 Financial Results and Business Updates

CNTY-813, lead beta islet cell therapy program as a potential functional cure for type 1 diabetes, in Investigational New Drug (IND)-enabling studies; IND submission expected in 4Q 2026 to support anticipated initial clinical data in 2H 2027CNTY-308, a CD19-targeted CAR-iT cell therapy engineered with Allo-Evasion™ 5.0, on track to enter the clinic in 2026Strengthened balance sheet and cash runway extended into 1Q 2029 from oversubscribed $135 million private placement in January 2026 PHILADELPH

finance.yahoo.com logo
Mar 12 • 8:00 AM EDT • Business • finance.yahoo.com